---
title: "EU court upholds EU antitrust veto of Booking's ETraveli deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298417207.md"
datetime: "2026-09-09T07:42:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298417207.md)
  - [en](https://longbridge.com/en/news/298417207.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298417207.md)
generator: "portal-rs"
---

# EU court upholds EU antitrust veto of Booking's ETraveli deal

BRUSSELS, Sept 9 (Reuters) - Europe’s second-highest court on Wednesday sided with EU antitrust regulators which blocked Booking Holdings’ €1.63 billion ($1.9 billion) ETraveli acquisition three years ago, as they rejected the U.S. online travel company’s arguments.

The European Commission, in its 2023 decision, said the deal would have created a travel ecosystem for Booking, leaving rivals unable to compete.

The Luxembourg-based General Court agreed with the EU competition enforcer.

“The Commission found, correctly, that the acquisition of Etraveli Group, Europe’s leading online flight booking operator, would have strengthened Booking’s already dominant position on the market for online travel agencies in the hotel sector,” judges said.

The case is T-1139⁄23 Booking Holdings v Commission.

($1 = 0.8593 euros)

### Related Stocks

- [BKNG.US](https://longbridge.com/en/quote/BKNG.US.md)
- [BKNU.US](https://longbridge.com/en/quote/BKNU.US.md)

## Related News & Research

- [Beacon Investment Advisory Services Inc. Purchases 108,383 Shares of Booking Holdings Inc. $BKNG](https://longbridge.com/en/news/298422545.md)
- [Booking Holdings Inc. $BKNG Shares Purchased by Angeles Wealth Management LLC](https://longbridge.com/en/news/298178905.md)
- [Booking Holdings Inc. $BKNG Shares Acquired by NewEdge Advisors LLC](https://longbridge.com/en/news/298699235.md)
- [Syon Capital LLC Has $1.69 Million Stake in Booking Holdings Inc. $BKNG](https://longbridge.com/en/news/298107218.md)
- [Labcorp buys MLM Medical Labs](https://longbridge.com/en/news/298332531.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**